CEACAM5 and colorectal carcinoma: Currently, few available clinical biomarkers such as CEA and CA19-9 have been reported with low sensitivity and specificity for early detection of CRC (Nicolini et al., 2010; Lee et al., 2012; Su et al., 2012).